NEO
NeoGenomics Inc
NASDAQ: NEO · HEALTHCARE · DIAGNOSTICS & RESEARCH
$8.96
-0.67% today
Updated 2026-04-29
Market cap
$1.17B
P/E ratio
—
P/S ratio
1.60x
EPS (TTM)
$-0.84
Dividend yield
—
52W range
$5 – $14
Volume
2.1M
NeoGenomics Inc (NEO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
+10.6%
Most recent quarter
EPS YoY growth
+50.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-9.9%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-21.1%
2025-07-29
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-17 | $0.06 | +50.0% | $11.38 | $10.26 | -9.8% |
| 2025-10-28 | $0.03 | +50.0% | $10.16 | $10.28 | +1.2% |
| 2025-07-29 | $0.03 | +50.0% | $6.46 | $5.10 | -21.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.04 | $0.06 | +50.0% | $190.17M | +10.6% |
| 2025-09-30 | $0.02 | $0.03 | +50.0% | $187.80M | +11.9% |
| 2025-06-30 | $0.02 | $0.03 | +50.0% | $181.33M | +10.2% |
| 2025-03-31 | $-0.01 | $-0.20 | -3970.0% | $168.03M | +7.5% |
| 2024-12-31 | $0.03 | $0.04 | +39.9% | $172.00M | +10.6% |
| 2024-09-30 | $0.01 | $-0.14 | -1494.0% | $167.82M | +10.4% |
| 2024-06-30 | $-0.00 | $0.03 | +1404.3% | $164.50M | +12.0% |
| 2024-03-31 | $-0.05 | $-0.02 | +60.0% | $156.24M | — |
| 2023-12-31 | $-0.02 | $0.03 | +250.0% | $155.55M | — |
| 2023-09-30 | $-0.07 | $-0.15 | -110.4% | $151.95M | — |
| 2023-06-30 | $-0.11 | $-0.05 | +54.5% | $146.92M | — |
Frequently asked questions
Has NeoGenomics Inc beaten earnings estimates?
NeoGenomics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports.
How does NEO stock react to earnings?
NEO stock has moved an average of -9.9% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is NeoGenomics Inc's revenue growth rate?
NeoGenomics Inc reported year-over-year revenue growth of +10.6% in its most recent quarter, with EPS growing +50.0% year-over-year.